Skip to content

Spontaneous Coronary Artery Dissection National Swiss Registry

Spontaneous Coronary Artery Dissection (SCAD) National Swiss Registry (SwissSCAD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04457544
Acronym
SwissSCAD
Enrollment
1000
Registered
2020-07-07
Start date
2020-08-12
Completion date
2030-06-30
Last updated
2022-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous Coronary Artery Dissection

Brief summary

Spontaneous coronary artery dissection (SCAD), is an underdiagnosed pathology, affecting predominantly young women without traditional cardiovascular risk factors and is associated with major adverse outcomes including myocardial infarction, cardiac arrest, or death. Timely diagnosis of SCAD as well as clinical follow-up are of the essence in this pathology associated with major cardiac adverse outcomes. Despite recent improvements in diagnosis and recognition of the importance of SCAD, it remains poorly studied and understood. In this context, we designed the SwissSCAD registry, a large, observational, prospective, cohort study, to describe the natural history of SCAD, its outcomes and its treatments.

Interventions

None listed

Sponsors

Dr. Sophie Degrauwe
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Subject is ≥18 years of age. * Patient presenting newly diagnosed SCAD or diagnosed with SCAD within the last 5 years. * Subject must be willing to sign a Patient Informed Consent (PIC).

Exclusion criteria

* Patient unwilling or unable to provide informed consent. * Patients with atherosclerotic or iatrogenic coronary dissection.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of safety events at 30 days30 daysIncidence of Major cardiovascular outcomes (MACE) at 30 days

Secondary

MeasureTime frameDescription
Incidence of safety events at 1 year1 yearIncidence of Major cardiovascular outcomes (MACE) at 1 year
Incidence of safety events at 5 years5 yearsIncidence of Major cardiovascular outcomes (MACE) at 5 years

Countries

Switzerland

Contacts

Primary ContactSophie Degrauwe, Dr
sophie.degrauwe@hcuge.ch+41795530294
Backup ContactVeronique Menoni, PhD
Veronique.Menoni@hcuge.ch+41795530917

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026